Medical Updates Digest

Clinical and administrative data remain trapped in separate systems, blocking the operational breakthroughs seen in other industries. Mandates like...

Holland Bloorview demonstrates how organizations can move from equity pledges to sustained action through data, partnerships, and learning systems.
-...

A small trial of topical vitamin C in DMSO achieved complete histologic clearance in 56% of 27 biopsy-confirmed squamous cell carcinoma in situ...

Three studies from WCLC 2026 offer promising signals across lung cancer subtypes, yet remain far from changing practice.

• ROS1-positive NSCLC:...

Cancer research is shifting from tumor-only focus to viewing cancer as a whole-body disease.

• Immune activation is emerging as a key treatment lens...

The World Cancer Congress serves as a key platform for global institutions like IARC to share research and launch collaborations, exemplified by their...

Voters now rank healthcare affordability among their top priorities alongside food and shelter, forcing candidates to address costs directly or risk...

The FDA has classified a voluntary recall of over 13,000 bottles of chlorthalidone 25 mg tablets as Class II due to failed dissolution specs.

-...

• Standardized surveillance now requires all hospitals to report device malfunctions, design flaws, and near-misses without delay.
• Serious events...

AI is rapidly advancing breast cancer detection, diagnosis, prognosis, and treatment-response assessment by analyzing high-dimensional imaging,...

Cross-border mentorship networks are expanding cancer research capacity in low-resource settings by linking senior experts with junior investigators...

Gene therapy breakthroughs offer curative potential for sickle cell disease, yet healthcare disparities in access, affordability, and specialist care remain widespread for patients nationwide.

AI tools for insurance claims added $942 million in spending over two years, driven by a sharp rise in complex-condition coding. Analysis found no...

Florida is directing state grants to extend cancer innovation and trials beyond academic centers into community and rural settings.

• $6 million...

Clinical validation, outcomes data, and ethical governance must come first before scaling AI in cancer research and care, to avoid magnifying biases, privacy risks, and inequities while preserving human dignity and consent.

Moral judgments continue to divide disabled people into "innocent" and "guilty" categories, shaping who is seen as deserving of care.

• Moral model...

Trastuzumab rezetecan delivered meaningful gains in progression-free survival and response rates versus standard care for chemotherapy-refractory,...

New oral GLP-1 medications aim to deliver injectable-level benefits without needles, yet they require strict adherence to dosing schedules.

UiPath awards highlight agentic AI efficiency in healthcare, yet verifiable clinical impact and governance risks remain unclear.

• Omega Healthcare...

• High-speed advantage: MAUL evacuation robots reach 72 km/h, outrunning drone attacks and delivering wounded faster than standard 12 km/h UGVs.
  -...